134 related articles for article (PubMed ID: 35399003)
1. Comparison of the copy-neutral loss of heterozygosity identified from whole-exome sequencing data using three different tools.
Lee GT; Chung YJ
Genomics Inform; 2022 Mar; 20(1):e4. PubMed ID: 35399003
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing for fetal loss of heterozygosity using single nucleotide polymorphism array and whole-exome sequencing.
Xue H; Yu A; Zhang L; Chen L; Guo Q; Lin M; Lin N; Chen X; Xu L; Huang H
Sci Rep; 2024 Jan; 14(1):2190. PubMed ID: 38273042
[TBL] [Abstract][Full Text] [Related]
4. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
5. Somatic mosaicism for copy-neutral loss of heterozygosity and DNA copy number variations in the human genome.
Žilina O; Koltšina M; Raid R; Kurg A; Tõnisson N; Salumets A
BMC Genomics; 2015 Sep; 16(1):703. PubMed ID: 26376747
[TBL] [Abstract][Full Text] [Related]
6. Primary mediastinal large B-cell lymphoma is characterized by large-scale copy-neutral loss of heterozygosity.
Tuveri S; Debackere K; Marcelis L; Dierckxsens N; Demeulemeester J; Dimitriadou E; Dierickx D; Lefesvre P; Deraedt K; Graux C; Michaux L; Cools J; Tousseyn T; Vermeesch JR; Wlodarska I
Genes Chromosomes Cancer; 2022 Oct; 61(10):603-615. PubMed ID: 35611992
[TBL] [Abstract][Full Text] [Related]
7. Distinct genomic profiles of gestational choriocarcinoma, a unique cancer of pregnant tissues.
Jung SH; Choi YJ; Kim MS; Park HC; Han MR; Hur SY; Lee AW; Shin OR; Kim J; Lee SH; Hong D; Song SY; Chung YJ; Lee SH
Exp Mol Med; 2020 Dec; 52(12):2046-2054. PubMed ID: 33319857
[TBL] [Abstract][Full Text] [Related]
8. aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations.
Renault V; Tost J; Pichon F; Wang-Renault SF; Letouzé E; Imbeaud S; Zucman-Rossi J; Deleuze JF; How-Kit A
PLoS One; 2017; 12(12):e0189334. PubMed ID: 29261730
[TBL] [Abstract][Full Text] [Related]
9. Renal angiomyolipoma (AML) harboring a missense mutation of
Idogawa M; Hida T; Tanaka T; Ohira N; Tange S; Sasaki Y; Uhara H; Masumori N; Tokino T; Natori H
Cancer Biol Ther; 2020 Apr; 21(4):315-319. PubMed ID: 31847710
[TBL] [Abstract][Full Text] [Related]
10. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide identification of copy neutral loss of heterozygosity reveals its possible association with spatial positioning of chromosomes.
Kim H; Suyama M
Hum Mol Genet; 2023 Mar; 32(7):1175-1183. PubMed ID: 36349694
[TBL] [Abstract][Full Text] [Related]
12. Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response.
Kumar Y; Yang J; Hu T; Chen L; Xu Z; Xu L; Hu XX; Tang G; Wang JM; Li Y; Poon WS; Wan W; Zhang L; Mat WK; Pun FW; Lee P; Cheong TH; Ding X; Ng SK; Tsang SY; Chen JF; Zhang P; Li S; Wang HY; Xue H
BMC Med Genomics; 2015 Jul; 8():42. PubMed ID: 26208496
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors.
Kryh H; Carén H; Erichsen J; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
BMC Genomics; 2011 Sep; 12():443. PubMed ID: 21899760
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.
Koh KN; Lee JO; Seo EJ; Lee SW; Suh JK; Im HJ; Seo JJ
J Korean Med Sci; 2014 Jul; 29(7):926-33. PubMed ID: 25045224
[TBL] [Abstract][Full Text] [Related]
15. Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia.
Betensky M; Babushok D; Roth JJ; Mason PJ; Biegel JA; Busse TM; Li Y; Lind C; Papazoglou A; Monos D; Podsakoff G; Bessler M; Olson TS
Cancer Genet; 2016; 209(1-2):1-10. PubMed ID: 26702937
[TBL] [Abstract][Full Text] [Related]
16. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma.
Hu N; Clifford RJ; Yang HH; Wang C; Goldstein AM; Ding T; Taylor PR; Lee MP
BMC Genomics; 2010 Oct; 11():576. PubMed ID: 20955586
[TBL] [Abstract][Full Text] [Related]
17. An integrated Bayesian analysis of LOH and copy number data.
Rancoita PM; Hutter M; Bertoni F; Kwee I
BMC Bioinformatics; 2010 Jun; 11():321. PubMed ID: 20550648
[TBL] [Abstract][Full Text] [Related]
18. SNP array genomic analysis of matched pairs of brain and liver metastases in primary colorectal cancer.
Brandt VP; Holland H; Wallenborn M; Koschny R; Frydrychowicz C; Richter M; Holland L; Nestler U; Sander C
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18173-18183. PubMed ID: 38010391
[TBL] [Abstract][Full Text] [Related]
19. Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.
Barresi V; Romano A; Musso N; Capizzi C; Consoli C; Martelli MP; Palumbo G; Di Raimondo F; Condorelli DF
Genes Chromosomes Cancer; 2010 Nov; 49(11):1014-23. PubMed ID: 20725993
[TBL] [Abstract][Full Text] [Related]
20. Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations.
Saeki H; Kitao H; Yoshinaga K; Nakanoko T; Kubo N; Kakeji Y; Morita M; Maehara Y
Clin Cancer Res; 2011 Apr; 17(7):1731-40. PubMed ID: 21325068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
